Tag: accelerate
Posted in WP-12
Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine
Author: BLOGGER Published Date: 10/07/2024
CROSSJECT Key contribution to the acceleration of the development of ZENEO® Epinephrine Financial support includes mainly grants, as well as subsidized loans France 2030 Plan dedicated to supporting French companies demonstrating outstanding growth and innovation potential Dijon, France, July 10th, 2024 07:30 CET — Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company in advanced …